ArticleFrontiers in endocrinology2026
Effect of atrazine and curcumin on mouse I-10 Leydig cells: steroidogenesis and beyond.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic exposure to pesticides is increasingly becoming a concern in the modern world. Atrazine (ATZ), a widely used pesticide in the U.S., is known to interfere with the male reproductive system. In the present study, we examined the effects of ATZ on viability, cell cycle progression, steroid production, and steroidogenic gene expression profile of testicular Leydig cells using the mouse Leydig cell line I-10 as an Methods: I-10 cells were treated for 6 days with either ATZ (3.3, 10, 33, 100 µM), Cur (3, 10, 30 µM), or a co-treatment of Cur (3 µM) + ATZ (33 or 100 µM). Cell viability, cell cycle progression, production of progesterone (P4) and testosterone (T), and expression of key steroidogenic genes were assessed on Days 2, 4, and 6. Additionally, AutoDock Vina v1.2.7 was used to predict the binding affinities of Cur and ATZ to key mouse and human steroidogenic proteins in comparison to their endogenous substrates. Results: ATZ decreased I-10 cell viability while increasing T levels in a concentration-dependent manner. Cur transiently stimulated I-10 cell proliferation and increased P4 but showed mixed effects on T levels. Co-treatment decreased viability, as supported by changes in cell cycle distributions. Co-treatment also significantly increased both P4 and T production, with induction of expression of the steroidogenic genes StAR, Cyp11a1, Hsd3β6, and Hsd17β3 at specific time points. Furthermore, Cur exhibited strong predicted binding to both mouse and human steroidogenic proteins, comparable to that of their endogenous substrates. Conclusion: Our findings suggest a potential interaction between Cur and ATZ, which was more prominent at ATZ 100 μM, stimulating steroidogenesis in I-10 Leydig cells at the expense of decreased viability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.